肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

连续性血液净化在儿童危重症应用的专家共识

2021-05-18 中华儿科杂志.2021.59(5):352-360.

连续性血液净化

近20年来，随着儿童重症医学的进步和连续性血液净化（CBP）技术的发展，CBP技术越来越多地应用于儿童危重症的救治，已经成为体外生命支持系统的重要组成之一。但我国儿童危重症领域CBP技术发展不平衡，对

中文标题：

连续性血液净化在儿童危重症应用的专家共识

发布机构：

发布日期：

2021-05-18

简要介绍：

近20年来，随着儿童重症医学的进步和连续性血液净化（CBP）技术的发展，CBP技术越来越多地应用于儿童危重症的救治，已经成为体外生命支持系统的重要组成之一。但我国儿童危重症领域CBP技术发展不平衡，对其认识和实践有待提高。本共识旨在指导和规范我国儿童危重症CBP技术的临床实践。

相关资料下载：
[AttachmentFileName(sort=1, fileName=连续性血液净化在儿童危重症应用的专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=9735e1c0021096dd, title=连续性血液净化在儿童危重症应用的专家共识, enTitle=, guiderFrom=中华儿科杂志.2021.59(5):352-360., authorId=0, author=, summary=近20年来，随着儿童重症医学的进步和连续性血液净化（CBP）技术的发展，CBP技术越来越多地应用于儿童危重症的救治，已经成为体外生命支持系统的重要组成之一。但我国儿童危重症领域CBP技术发展不平衡，对, cover=https://img.medsci.cn/2021530/1622304457692_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue May 18 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>近20年来，随着儿童重症医学的进步和连续性血液净化（CBP）技术的发展，CBP技术越来越多地应用于儿童危重症的救治，已经成为体外生命支持系统的重要组成之一。但我国儿童危重症领域CBP技术发展不平衡，对其认识和实践有待提高。本共识旨在指导和规范我国儿童危重症CBP技术的临床实践。</p> </div> </div> </div>, tagList=[TagDto(tagId=112355, tagName=连续性血液净化)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=38508, guiderKeyword=血液净化, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7459, appHits=82, showAppHits=0, pcHits=640, showPcHits=7374, likes=1, shares=11, comments=3, approvalStatus=1, publishedTime=Sun May 30 00:27:37 CST 2021, publishedTimeString=2021-05-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun May 30 00:07:49 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 12:57:42 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=连续性血液净化在儿童危重症应用的专家共识.pdf)])
连续性血液净化在儿童危重症应用的专家共识.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201078, encodeId=efeb12010e82c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:28 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972882, encodeId=9d6a9e2882e8, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe01459391, createdName=mwq1969, createdTime=Fri Jun 11 16:00:48 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970031, encodeId=7e219e00312c, content=非常好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd1f5248924, createdName=147d8a66m32暂无昵称, createdTime=Tue Jun 01 10:10:29 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2022-03-09 ms9000001115066421

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1201078, encodeId=efeb12010e82c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:28 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972882, encodeId=9d6a9e2882e8, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe01459391, createdName=mwq1969, createdTime=Fri Jun 11 16:00:48 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970031, encodeId=7e219e00312c, content=非常好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd1f5248924, createdName=147d8a66m32暂无昵称, createdTime=Tue Jun 01 10:10:29 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-06-11 mwq1969

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201078, encodeId=efeb12010e82c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b0af5475963, createdName=ms9000001115066421, createdTime=Wed Mar 09 22:12:28 CST 2022, time=2022-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972882, encodeId=9d6a9e2882e8, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ffe01459391, createdName=mwq1969, createdTime=Fri Jun 11 16:00:48 CST 2021, time=2021-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970031, encodeId=7e219e00312c, content=非常好用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd1f5248924, createdName=147d8a66m32暂无昵称, createdTime=Tue Jun 01 10:10:29 CST 2021, time=2021-06-01, status=1, ipAttribution=)]
    2021-06-01 147d8a66m32暂无昵称

    非常好用

    0

拓展阅读

2016 非生物型人工肝/血液净化治疗儿童急性肝衰竭技术规范

中国儿科相关医学专家组（统称） · 2016-09-25

血液净化急诊临床应用专家共识

国内急诊/重症相关专家小组（统称） · 2016-01-01

连续性血液净化治疗新生儿急性肾损伤专家共识

中华医学会儿科学分会新生儿学组 · 2021-04-10

血液净化用中心静脉导管相关血流感染防控管理的最佳证据总结

西安交通大学第一附属医院 · 2024-03-15

重症患者血液净化低血压预防及管理的最佳证据总结

暂未更新 · 2024-07-10